News Briefs: Sentillion’s CCOW compliance enhances Microsoft dashboard

Article

Microsoft has chosen to make its Physician Digital Dashboard interface CCOW-compliant via Sentillion’s Vergence Context Management product. CCOW is part of the HL7 standard that establishes a common basis for synchronizing and coordinating access to

Microsoft has chosen to make its Physician Digital Dashboard interface CCOW-compliant via Sentillion’s Vergence Context Management product. CCOW is part of the HL7 standard that establishes a common basis for synchronizing and coordinating access to disparate applications containing patient information. CCOW-compliant software products work together “behind the scenes” through the Vergence context manager that enables them to act as a single system and information source from a clinician’s perspective. For the Microsoft Physician Digital Dashboard, Vergence will enable the various Web parts (data from multiple information sources displayed on the dashboard) to coexist within a single integrated interface, meaning that information on a specific patient can be pulled from various systems and displayed simultaneously on the dashboard. The dashboard product also incorporates selected Microsoft Office features in a browser-style environment.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.